Clinical Trials of America Launches Crohn’s Study:

Clinical Trials of America has  launched a Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely Active Crohn’s Disease Previously Treated with TNF Antagonist Therapy

Clinical Trials of America has been awarded a study to evaluate the general effect of of a novel study drug in obesity treatment. The study will measure the effect of the study drug on body weight in non-diabetic obese subjects or overweight subjects with comorbidities. The study is a randomised, double-blind, placebo controlled, parallel groeup, multi-centre, multinational trial with stratification of subject to either one or three years of treatment based on pre-diabetes status at randomisation

Within 2 months of opening a new site in Seattle Washington, Clinical Trials of America has launched a flu observation study. This is a prospective, multi-center study to examine natural prevalence and/or emergence of resistance to antivirals among influenza virus isolates and of the clinical outcome of patients with influenza.

Clinical Trials of America has launched a study to assess the impact of a novel study drug versus Insulin Glargine Both in Combination with Insulin Lispro for the Treatment to Target of Type2 Diabetes Mellitus

Clinical Trials of America has launched a Sample Collection Study for the Assessment of Novel Biomarkers of Placental Function and Maternal Adaptation in Healthy Pregnant Women without Pre-eclampsia.

FOR IMMEDIATE RELEASE Nov. 30, 2010

Clinical Trials of America Opens New Site in Seattle
and Names Kathy Hendricks as Manager

EUGENE, Ore. — Clinical Trials of America Inc. has announced the opening of a new Seattle site and named Kathy Hendricks as site manager. Hendricks leads operational and business development and oversees patient recruitment and relations.

“The opening of the Seattle site is the next phase of expansion for Clinical Trials of America,” said President Don Dickerson. “We are leveraging the core strengths of the company’s headquarters in Eugene and building a solid platform beyond Lane County.”

Hendricks brings more than a decade of clinical research and medical assistance experience to her new position and offers a wealth of knowledge to the Clinical Trials of America team. Hendricks has conducted more than 35 clinical trials. She has worked as a clinical research coordinator for research clinics in Washington and North Carolina.

“Her background, training and wide-ranging skill set will be great assets to Clinical Trials of America in the Seattle market,” Dickerson said.

Hendricks can be reached at (206) 769-3175. She reports to Dickerson.